The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy^*

References

• Goodnough LT, Nissenson AR. Anemia and its clinical consequences in patients with chronic diseases. Am J Med. 2004;116(Suppl 7A):1–2S
   Google Scholar
• Cella D, Dobrez D, Glaspy J. Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes. Ann Oncol 2003;14:511–19
   Google Scholar
• van der Werf MJ, van Benthem BH, van Ameijden EJ. Prevalence, incidence and risk factors of anaemia in HIV-positive and HIV-negative drug users. Addiction 2000;95: 383–92
   PubMed Web of Science ®Google Scholar
• Sarcletti M, Bitterlich W, Fuchs D, Zangerle R. Is the poorer rate of survival among patients with human immunodeficiency virus infection and anemia linked to immune activation? J Infect Dis 2002;186:141–3
   PubMed Web of Science ®Google Scholar
• Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA Study Group. AIDS 1999;13:943–50
   Google Scholar
• Pujade-Lauraine E, Gascón P. The burden of anaemia in patients with cancer. Oncology 2004;67(Suppl 1):1–4
   PubMedGoogle Scholar
• Mildvan D, Creagh TC, Leitz G. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human immunodeficiency virus-infected patients: findings of the Anemia Prevalence Study. Cur Med Res Opin 2007;23: 343–55
   Google Scholar
• Breitbart W, McDonald MV, Rosenfeld B, et al. Fatigue in ambulatory AIDS patients. J Pain Symptom Manage 1998;15:159–67
   PubMed Web of Science ®Google Scholar
• Groopman JE. Fatigue in cancer and HIV/AIDS. Oncology 1998;12:335–44
   PubMed Web of Science ®Google Scholar
• Barroso J. A review of fatigue in people with HIV infection. J Assoc Nurses AIDS Care 1999;10:42–9
   PubMedGoogle Scholar
• Saag MS, Bowers P, Leitz GJ, Levine AM. Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients. AIDS Res Hum Retroviruses 2004;20:1037–45
   PubMed Web of Science ®Google Scholar
• Abrams DI, Steinhart C, Frascino R. Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life. Int J STD AIDS 2000;11:659–65
   Google Scholar
• Grossman HA, Goon B, Bowers P, Leitz G; 010 Study Group. Once-weekly epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with improved quality of life in anemic HIV-infected patients. J Acquir Immune Defic Syndr 2003;34:368–78
   Google Scholar
• Revicki DA, Brown RE, Henry DH, et al. Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. J Acquir Immune Defic Syndr 1994;7:474–84
   PubMed Web of Science ®Google Scholar
• Henry DH, Beall GN, Benson CA, et al. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med 1992;117:739–48
   PubMed Web of Science ®Google Scholar
• Berndt E, Crown W, Kallich J, et al. The impact of anaemia and its treatment on employee disability and medical costs. Pharmacoeconomics. 2005;23:183–92
   PubMed Web of Science ®Google Scholar
• Robinson B. Cost of anemia in the elderly. J Am Geriatr Soc 2003;51(Suppl 3):S14–17
   PubMed Web of Science ®Google Scholar
• Collins AJ, Li S, Ebben J, et al. Hematocrit levels and associated Medicare expenditures. Am J Kidney Dis 2000;36:282–93
   PubMed Web of Science ®Google Scholar
• Nissenson AR, Wade S, Goodnough T, et al. Economic burden of anemia in an insured population. J Manag Care Pharm 2005;11:565–74
   PubMedGoogle Scholar
• Ershler WB, Chen K, Reyes EB, Dubois R. Economic burden of patients with anemia in selected diseases. Value Health 2005;8:629–38
   PubMed Web of Science ®Google Scholar
• Lyman GH, Berndt ER, Kallich JD, et al. The economic burden of anemia in cancer patients receiving chemotherapy Value Health 2005;8:149–56
   Google Scholar
• Ware JE, Kosinski M, Dewey JE, Gandek B. A Manual for Users of the SF-8 Health Survey. Lincoln, RI. QualityMetric Incorporated, 2001
   Google Scholar
• Ware, JE. SF-36 Health Survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center, 1993
   Google Scholar
• Saunders DS, Burgoyne RW. Evaluating health-related wellbeing outcomes among outpatient adults with human immuno-deficiency virus infection in the HAART era. Int J STD AIDS 2002;13:683–90
   PubMed Web of Science ®Google Scholar
• Burgoyne R, Renwick R. Social support and quality of life over time among adults living with HIV in the HAART era. Soc Sci Med 2004;58:1353–66
   PubMed Web of Science ®Google Scholar
• Henderson M, Safa F, Easterbrook P, Hotopf M. Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy. HIV Med 2005;6:347–52
   PubMed Web of Science ®Google Scholar
• Wills TS, Nadler JP, Somboonwit C, et al. Anemia prevalence and associated risk factors in a single-center ambulatory HIV clinical cohort. AIDS Read 2004;14:305–15
   PubMedGoogle Scholar
• Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004;116(Suppl 7a): 27–43
   Google Scholar
• Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double blind, placebo-controlled trial. N Engl J Med 1987;317:192–7
   PubMed Web of Science ®Google Scholar
• Fischl M, Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488–93
   PubMed Web of Science ®Google Scholar
• Berhane K, Karim R, Cohen M, et al. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2004;37:1245–52
   PubMed Web of Science ®Google Scholar